​

LeonaBio (LONA) Stock Forecast, Price Target & Predictions

OverviewFinancialsChart

LONA Stock Forecast

LeonaBio (LONA) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $15.00, with a high of $20.00 and a low of $10.00. This represents a 50.30% increase from the last price of $9.98.

- $4 $8 $12 $16 $20 High: $20 Avg: $15 Low: $10 Last Closed Price: $9.98

LONA Stock Rating

LeonaBio stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (57.14%), 3 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 3 4 Strong Sell Sell Hold Buy Strong Buy

LONA Price Target Upside V Benchmarks

TypeNameUpside
StockLeonaBio50.30%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-13
Avg Price Target-$20.00$11.33
Last Closing Price$9.98$9.98$9.98
Upside/Downside-100.40%13.53%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2612---3
Jun, 26121--4
May, 26-21--3
Apr, 26-21--3
Mar, 26-21--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 27, 2026Kelsey GoodwinPiper Sandler$20.00$9.67106.83%100.40%
Feb 18, 2026Mizuho Securities$10.00$4.76110.08%0.20%
Sep 19, 2025Graig SuvannavejhMizuho Securities$4.00$3.834.44%-59.92%
Jun 22, 2022Andrew TsaiJefferies$3.00$2.855.26%-69.94%
Apr 21, 2022Berenberg Bank$33.00$11.63183.75%230.66%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 27, 2026Piper SandlerOverweightinitialise
Feb 26, 2026Cantor FitzgeraldOverweightinitialise
Sep 04, 2024Rodman & RenshawBuyNeutraldowngrade
Sep 04, 2024JMP SecuritiesPerformMarket Performdowngrade
Sep 04, 2024JMP SecuritiesMarket OutperformPerformdowngrade
Sep 04, 2024BTIGNeutralPositivedowngrade
Sep 03, 2024BTIGNeutraldowngrade
Aug 19, 2024Rodman & RenshawBuyinitialise
Oct 17, 2022JMP SecuritiesMarket Outperformupgrade
Jun 22, 2022JefferiesBuydowngrade

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-25.20$-24.70----
Avg Forecast$-25.10$-6.24$-4.87$-0.40$-0.43$-0.45
High Forecast$-25.10$-6.24$-4.71$-0.40$-0.43$-0.45
Low Forecast$-25.10$-6.24$-5.03$-0.40$-0.43$-0.45
Surprise %0.40%295.83%----

Revenue Forecast

Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported------
Avg Forecast------
High Forecast------
Low Forecast------
Surprise %------

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-96.94M$-105.61M----
Avg Forecast$-96.59M$-24.02M$-18.74M$-1.54M$-1.65M$-1.73M
High Forecast$-96.59M$-24.02M$-18.13M$-1.54M$-1.65M$-1.73M
Low Forecast$-96.59M$-24.02M$-19.35M$-1.54M$-1.65M$-1.73M
Surprise %0.37%339.76%----

LONA Forecast FAQ

Is LeonaBio stock a buy?

LeonaBio stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LeonaBio is a favorable investment for most analysts.

What is LeonaBio's price target?

LeonaBio's price target, set by 7 Wall Street analysts, averages $15 over the next 12 months. The price target range spans from $10 at the low end to $20 at the high end, suggesting a potential 50.30% change from the previous closing price of $9.98.

How does LeonaBio stock forecast compare to its benchmarks?

LeonaBio's stock forecast shows a 50.30% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for LeonaBio over the past three months?

  • July 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 66.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is LeonaBio’s EPS forecast?

LeonaBio's average annual EPS forecast for its fiscal year ending in December 2026 is $-4.87, marking a -80.28% decrease from the reported $-24.7 in 2025. Estimates for the following years are $-0.4 in 2027, $-0.43 in 2028, and $-0.45 in 2029.

What is LeonaBio’s revenue forecast?

LeonaBio's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $0, followed by $0 for 2028, and $0 for 2029.

What is LeonaBio’s net income forecast?

LeonaBio's net income forecast for the fiscal year ending in December 2026 stands at $-18.74M, representing a -82.26% decrease from the reported $-106M in 2025. Projections indicate $-1.539M in 2027, $-1.655M in 2028, and $-1.732M in 2029.